title: Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects.
abstract: The authors found that growth hormone (GH) response to edrophonium was no different in 12 Alzheimer's disease patients than in eight healthy elderly subjects. Previously reported differences could be due to differences in gender or baseline GH concentrations between patients and control subjects.
authors.affiliation: Department of Psychiatry, Bronx VA Medical Center, NY 10468.
authors.forename: M
authors.initials: M
authors.lastname: Davidson
authors.forename: B M
authors.initials: BM
authors.lastname: Davis
authors.forename: L
authors.initials: L
authors.lastname: Bastiaens
authors.forename: J
authors.initials: J
authors.lastname: Macaluso
authors.forename: M
authors.initials: M
authors.lastname: Aryan
authors.forename: T
authors.initials: T
authors.lastname: Ryan
authors.forename: K L
authors.initials: KL
authors.lastname: Davis
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D004491:Edrophonium; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D004491:Edrophonium; D013006:Growth Hormone